The modified catalysts were treated with a range of acids and the acid salt forms were used as catalysts for ring-closing metathesis (RCM) reactions.
To determine whether RAD288 and RAD289 affect the cell viability and proliferation of mOECs, cells were treated with a range of concentrations from 0.02 to 12.5 µM of RAD288 and RAD289 for 24 h.
To determine if Schwann cells also responded to RAD288 and RAD289, Schwann cells were treated with a range of concentrations from 0.78 to 6.25 µM of RAD288 and RAD289 for 24 h.
Groups of rats were treated with a range of doses of the model neurotoxicants, acrylamide (0, 2, 10, 50 mg/kg) and methylmercury (0, 0.2, 1, 5 mg/kg) for up to 3 weeks and samples of serum, urine, and cerebral spinal fluid analysed by surface-enhanced laser desorption/ionisation-time-of-flight mass spectrometry.
Cells were treated with a range of concentrations of ZnO NPs for 24 h.
Subsequently, the cells were treated with a range of dilution ratios of C. wenyujin extract for 48 h.
Considering the Stroop test as a speed-dependent test could explain poorer performance among patients treated with a range of substances.
After the monolayer of cells became formed for 36 h, cells were treated with a range of concentrations of different Lf nanoliposomes and Lf.
After the monolayer of cells became formed for 36 h, the cells were treated with a range of concentrations of different EGCG nanoliposomes and EGCG.
Unlike the strains found in hospitals, most of these new cases of MRSA can still be treated with a range of antibiotics.
After the monolayer of cells was placed in 6, 24, or 96-well plates, the cells were treated with a range of concentrations of nano-sized ZnO particles suspended in medium without serum for 24 h.
